Global Dry Powder Inhaler Device Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Summary
A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.
According to APO Research, The global Dry Powder Inhaler Device market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Dry Powder Inhaler Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Dry Powder Inhaler Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Dry Powder Inhaler Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Dry Powder Inhaler Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Dry Powder Inhaler Device include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Dry Powder Inhaler Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Dry Powder Inhaler Device, also provides the sales of main regions and countries. Of the upcoming market potential for Dry Powder Inhaler Device, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dry Powder Inhaler Device sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Dry Powder Inhaler Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Dry Powder Inhaler Device sales, projected growth trends, production technology, application and end-user industry.
Dry Powder Inhaler Device segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Powder Inhaler Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dry Powder Inhaler Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Powder Inhaler Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Dry Powder Inhaler Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dry Powder Inhaler Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dry Powder Inhaler Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Dry Powder Inhaler Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.
According to APO Research, The global Dry Powder Inhaler Device market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Dry Powder Inhaler Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Dry Powder Inhaler Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Dry Powder Inhaler Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Dry Powder Inhaler Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Dry Powder Inhaler Device include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Dry Powder Inhaler Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Dry Powder Inhaler Device, also provides the sales of main regions and countries. Of the upcoming market potential for Dry Powder Inhaler Device, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dry Powder Inhaler Device sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Dry Powder Inhaler Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Dry Powder Inhaler Device sales, projected growth trends, production technology, application and end-user industry.
Dry Powder Inhaler Device segment by Company
- GlaxoSmithKline
- AstraZeneca
- Boehringer Ingelheim
- Chiesi
- Cipla
- 3M
- Hovione
- Mannkind
- Mylan
- Novartis
- Schering/Merck
- Teva
- Vectura
- Single Dose
- Multi Dose
- Asthma
- COPD
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Powder Inhaler Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dry Powder Inhaler Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Powder Inhaler Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Dry Powder Inhaler Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dry Powder Inhaler Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dry Powder Inhaler Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Dry Powder Inhaler Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Dry Powder Inhaler Device Market Size, 2019 VS 2023 VS 2030
1.3 Global Dry Powder Inhaler Device Market Size Estimates and Forecasts (2019-2030)
1.4 Global Dry Powder Inhaler Device Sales Estimates and Forecasts (2019-2030)
1.5 Global Dry Powder Inhaler Device Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL DRY POWDER INHALER DEVICE MARKET DYNAMICS
2.1 Dry Powder Inhaler Device Industry Trends
2.2 Dry Powder Inhaler Device Industry Drivers
2.3 Dry Powder Inhaler Device Industry Opportunities and Challenges
2.4 Dry Powder Inhaler Device Industry Restraints
3 DRY POWDER INHALER DEVICE MARKET BY MANUFACTURERS
3.1 Global Dry Powder Inhaler Device Revenue by Manufacturers (2019-2024)
3.2 Global Dry Powder Inhaler Device Sales by Manufacturers (2019-2024)
3.3 Global Dry Powder Inhaler Device Average Sales Price by Manufacturers (2019-2024)
3.4 Global Dry Powder Inhaler Device Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Dry Powder Inhaler Device Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Dry Powder Inhaler Device Manufacturers, Product Type & Application
3.7 Global Dry Powder Inhaler Device Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Dry Powder Inhaler Device Market CR5 and HHI
3.8.2 Global Top 5 and 10 Dry Powder Inhaler Device Players Market Share by Revenue in 2023
3.8.3 2023 Dry Powder Inhaler Device Tier 1, Tier 2, and Tier
4 DRY POWDER INHALER DEVICE MARKET BY TYPE
4.1 Dry Powder Inhaler Device Type Introduction
4.1.1 Single Dose
4.1.2 Multi Dose
4.2 Global Dry Powder Inhaler Device Sales by Type
4.2.1 Global Dry Powder Inhaler Device Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Dry Powder Inhaler Device Sales by Type (2019-2030)
4.2.3 Global Dry Powder Inhaler Device Sales Market Share by Type (2019-2030)
4.3 Global Dry Powder Inhaler Device Revenue by Type
4.3.1 Global Dry Powder Inhaler Device Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Dry Powder Inhaler Device Revenue by Type (2019-2030)
4.3.3 Global Dry Powder Inhaler Device Revenue Market Share by Type (2019-2030)
5 DRY POWDER INHALER DEVICE MARKET BY APPLICATION
5.1 Dry Powder Inhaler Device Application Introduction
5.1.1 Asthma
5.1.2 COPD
5.1.3 Others
5.2 Global Dry Powder Inhaler Device Sales by Application
5.2.1 Global Dry Powder Inhaler Device Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Dry Powder Inhaler Device Sales by Application (2019-2030)
5.2.3 Global Dry Powder Inhaler Device Sales Market Share by Application (2019-2030)
5.3 Global Dry Powder Inhaler Device Revenue by Application
5.3.1 Global Dry Powder Inhaler Device Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Dry Powder Inhaler Device Revenue by Application (2019-2030)
5.3.3 Global Dry Powder Inhaler Device Revenue Market Share by Application (2019-2030)
6 GLOBAL DRY POWDER INHALER DEVICE SALES BY REGION
6.1 Global Dry Powder Inhaler Device Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Dry Powder Inhaler Device Sales by Region (2019-2030)
6.2.1 Global Dry Powder Inhaler Device Sales by Region (2019-2024)
6.2.2 Global Dry Powder Inhaler Device Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Dry Powder Inhaler Device Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Dry Powder Inhaler Device Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Dry Powder Inhaler Device Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Dry Powder Inhaler Device Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Dry Powder Inhaler Device Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Dry Powder Inhaler Device Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Dry Powder Inhaler Device Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Dry Powder Inhaler Device Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL DRY POWDER INHALER DEVICE REVENUE BY REGION
7.1 Global Dry Powder Inhaler Device Revenue by Region
7.1.1 Global Dry Powder Inhaler Device Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Dry Powder Inhaler Device Revenue by Region (2019-2024)
7.1.3 Global Dry Powder Inhaler Device Revenue by Region (2025-2030)
7.1.4 Global Dry Powder Inhaler Device Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Dry Powder Inhaler Device Revenue (2019-2030)
7.2.2 North America Dry Powder Inhaler Device Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Dry Powder Inhaler Device Revenue (2019-2030)
7.3.2 Europe Dry Powder Inhaler Device Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Dry Powder Inhaler Device Revenue (2019-2030)
7.4.2 Asia-Pacific Dry Powder Inhaler Device Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Dry Powder Inhaler Device Revenue (2019-2030)
7.5.2 LAMEA Dry Powder Inhaler Device Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 GlaxoSmithKline
8.1.1 GlaxoSmithKline Comapny Information
8.1.2 GlaxoSmithKline Business Overview
8.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio
8.1.5 GlaxoSmithKline Recent Developments
8.2 AstraZeneca
8.2.1 AstraZeneca Comapny Information
8.2.2 AstraZeneca Business Overview
8.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 AstraZeneca Dry Powder Inhaler Device Product Portfolio
8.2.5 AstraZeneca Recent Developments
8.3 Boehringer Ingelheim
8.3.1 Boehringer Ingelheim Comapny Information
8.3.2 Boehringer Ingelheim Business Overview
8.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio
8.3.5 Boehringer Ingelheim Recent Developments
8.4 Chiesi
8.4.1 Chiesi Comapny Information
8.4.2 Chiesi Business Overview
8.4.3 Chiesi Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Chiesi Dry Powder Inhaler Device Product Portfolio
8.4.5 Chiesi Recent Developments
8.5 Cipla
8.5.1 Cipla Comapny Information
8.5.2 Cipla Business Overview
8.5.3 Cipla Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Cipla Dry Powder Inhaler Device Product Portfolio
8.5.5 Cipla Recent Developments
8.6 3M
8.6.1 3M Comapny Information
8.6.2 3M Business Overview
8.6.3 3M Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 3M Dry Powder Inhaler Device Product Portfolio
8.6.5 3M Recent Developments
8.7 Hovione
8.7.1 Hovione Comapny Information
8.7.2 Hovione Business Overview
8.7.3 Hovione Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Hovione Dry Powder Inhaler Device Product Portfolio
8.7.5 Hovione Recent Developments
8.8 Mannkind
8.8.1 Mannkind Comapny Information
8.8.2 Mannkind Business Overview
8.8.3 Mannkind Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Mannkind Dry Powder Inhaler Device Product Portfolio
8.8.5 Mannkind Recent Developments
8.9 Mylan
8.9.1 Mylan Comapny Information
8.9.2 Mylan Business Overview
8.9.3 Mylan Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Mylan Dry Powder Inhaler Device Product Portfolio
8.9.5 Mylan Recent Developments
8.10 Novartis
8.10.1 Novartis Comapny Information
8.10.2 Novartis Business Overview
8.10.3 Novartis Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Novartis Dry Powder Inhaler Device Product Portfolio
8.10.5 Novartis Recent Developments
8.11 Schering/Merck
8.11.1 Schering/Merck Comapny Information
8.11.2 Schering/Merck Business Overview
8.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Schering/Merck Dry Powder Inhaler Device Product Portfolio
8.11.5 Schering/Merck Recent Developments
8.12 Teva
8.12.1 Teva Comapny Information
8.12.2 Teva Business Overview
8.12.3 Teva Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Teva Dry Powder Inhaler Device Product Portfolio
8.12.5 Teva Recent Developments
8.13 Vectura
8.13.1 Vectura Comapny Information
8.13.2 Vectura Business Overview
8.13.3 Vectura Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 Vectura Dry Powder Inhaler Device Product Portfolio
8.13.5 Vectura Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Dry Powder Inhaler Device Value Chain Analysis
9.1.1 Dry Powder Inhaler Device Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Dry Powder Inhaler Device Production Mode & Process
9.2 Dry Powder Inhaler Device Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Dry Powder Inhaler Device Distributors
9.2.3 Dry Powder Inhaler Device Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Dry Powder Inhaler Device Market Size, 2019 VS 2023 VS 2030
1.3 Global Dry Powder Inhaler Device Market Size Estimates and Forecasts (2019-2030)
1.4 Global Dry Powder Inhaler Device Sales Estimates and Forecasts (2019-2030)
1.5 Global Dry Powder Inhaler Device Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL DRY POWDER INHALER DEVICE MARKET DYNAMICS
2.1 Dry Powder Inhaler Device Industry Trends
2.2 Dry Powder Inhaler Device Industry Drivers
2.3 Dry Powder Inhaler Device Industry Opportunities and Challenges
2.4 Dry Powder Inhaler Device Industry Restraints
3 DRY POWDER INHALER DEVICE MARKET BY MANUFACTURERS
3.1 Global Dry Powder Inhaler Device Revenue by Manufacturers (2019-2024)
3.2 Global Dry Powder Inhaler Device Sales by Manufacturers (2019-2024)
3.3 Global Dry Powder Inhaler Device Average Sales Price by Manufacturers (2019-2024)
3.4 Global Dry Powder Inhaler Device Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Dry Powder Inhaler Device Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Dry Powder Inhaler Device Manufacturers, Product Type & Application
3.7 Global Dry Powder Inhaler Device Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Dry Powder Inhaler Device Market CR5 and HHI
3.8.2 Global Top 5 and 10 Dry Powder Inhaler Device Players Market Share by Revenue in 2023
3.8.3 2023 Dry Powder Inhaler Device Tier 1, Tier 2, and Tier
4 DRY POWDER INHALER DEVICE MARKET BY TYPE
4.1 Dry Powder Inhaler Device Type Introduction
4.1.1 Single Dose
4.1.2 Multi Dose
4.2 Global Dry Powder Inhaler Device Sales by Type
4.2.1 Global Dry Powder Inhaler Device Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Dry Powder Inhaler Device Sales by Type (2019-2030)
4.2.3 Global Dry Powder Inhaler Device Sales Market Share by Type (2019-2030)
4.3 Global Dry Powder Inhaler Device Revenue by Type
4.3.1 Global Dry Powder Inhaler Device Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Dry Powder Inhaler Device Revenue by Type (2019-2030)
4.3.3 Global Dry Powder Inhaler Device Revenue Market Share by Type (2019-2030)
5 DRY POWDER INHALER DEVICE MARKET BY APPLICATION
5.1 Dry Powder Inhaler Device Application Introduction
5.1.1 Asthma
5.1.2 COPD
5.1.3 Others
5.2 Global Dry Powder Inhaler Device Sales by Application
5.2.1 Global Dry Powder Inhaler Device Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Dry Powder Inhaler Device Sales by Application (2019-2030)
5.2.3 Global Dry Powder Inhaler Device Sales Market Share by Application (2019-2030)
5.3 Global Dry Powder Inhaler Device Revenue by Application
5.3.1 Global Dry Powder Inhaler Device Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Dry Powder Inhaler Device Revenue by Application (2019-2030)
5.3.3 Global Dry Powder Inhaler Device Revenue Market Share by Application (2019-2030)
6 GLOBAL DRY POWDER INHALER DEVICE SALES BY REGION
6.1 Global Dry Powder Inhaler Device Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Dry Powder Inhaler Device Sales by Region (2019-2030)
6.2.1 Global Dry Powder Inhaler Device Sales by Region (2019-2024)
6.2.2 Global Dry Powder Inhaler Device Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Dry Powder Inhaler Device Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Dry Powder Inhaler Device Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Dry Powder Inhaler Device Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Dry Powder Inhaler Device Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Dry Powder Inhaler Device Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Dry Powder Inhaler Device Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Dry Powder Inhaler Device Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Dry Powder Inhaler Device Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL DRY POWDER INHALER DEVICE REVENUE BY REGION
7.1 Global Dry Powder Inhaler Device Revenue by Region
7.1.1 Global Dry Powder Inhaler Device Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Dry Powder Inhaler Device Revenue by Region (2019-2024)
7.1.3 Global Dry Powder Inhaler Device Revenue by Region (2025-2030)
7.1.4 Global Dry Powder Inhaler Device Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Dry Powder Inhaler Device Revenue (2019-2030)
7.2.2 North America Dry Powder Inhaler Device Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Dry Powder Inhaler Device Revenue (2019-2030)
7.3.2 Europe Dry Powder Inhaler Device Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Dry Powder Inhaler Device Revenue (2019-2030)
7.4.2 Asia-Pacific Dry Powder Inhaler Device Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Dry Powder Inhaler Device Revenue (2019-2030)
7.5.2 LAMEA Dry Powder Inhaler Device Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 GlaxoSmithKline
8.1.1 GlaxoSmithKline Comapny Information
8.1.2 GlaxoSmithKline Business Overview
8.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio
8.1.5 GlaxoSmithKline Recent Developments
8.2 AstraZeneca
8.2.1 AstraZeneca Comapny Information
8.2.2 AstraZeneca Business Overview
8.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 AstraZeneca Dry Powder Inhaler Device Product Portfolio
8.2.5 AstraZeneca Recent Developments
8.3 Boehringer Ingelheim
8.3.1 Boehringer Ingelheim Comapny Information
8.3.2 Boehringer Ingelheim Business Overview
8.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio
8.3.5 Boehringer Ingelheim Recent Developments
8.4 Chiesi
8.4.1 Chiesi Comapny Information
8.4.2 Chiesi Business Overview
8.4.3 Chiesi Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Chiesi Dry Powder Inhaler Device Product Portfolio
8.4.5 Chiesi Recent Developments
8.5 Cipla
8.5.1 Cipla Comapny Information
8.5.2 Cipla Business Overview
8.5.3 Cipla Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Cipla Dry Powder Inhaler Device Product Portfolio
8.5.5 Cipla Recent Developments
8.6 3M
8.6.1 3M Comapny Information
8.6.2 3M Business Overview
8.6.3 3M Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 3M Dry Powder Inhaler Device Product Portfolio
8.6.5 3M Recent Developments
8.7 Hovione
8.7.1 Hovione Comapny Information
8.7.2 Hovione Business Overview
8.7.3 Hovione Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Hovione Dry Powder Inhaler Device Product Portfolio
8.7.5 Hovione Recent Developments
8.8 Mannkind
8.8.1 Mannkind Comapny Information
8.8.2 Mannkind Business Overview
8.8.3 Mannkind Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Mannkind Dry Powder Inhaler Device Product Portfolio
8.8.5 Mannkind Recent Developments
8.9 Mylan
8.9.1 Mylan Comapny Information
8.9.2 Mylan Business Overview
8.9.3 Mylan Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Mylan Dry Powder Inhaler Device Product Portfolio
8.9.5 Mylan Recent Developments
8.10 Novartis
8.10.1 Novartis Comapny Information
8.10.2 Novartis Business Overview
8.10.3 Novartis Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 Novartis Dry Powder Inhaler Device Product Portfolio
8.10.5 Novartis Recent Developments
8.11 Schering/Merck
8.11.1 Schering/Merck Comapny Information
8.11.2 Schering/Merck Business Overview
8.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Schering/Merck Dry Powder Inhaler Device Product Portfolio
8.11.5 Schering/Merck Recent Developments
8.12 Teva
8.12.1 Teva Comapny Information
8.12.2 Teva Business Overview
8.12.3 Teva Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Teva Dry Powder Inhaler Device Product Portfolio
8.12.5 Teva Recent Developments
8.13 Vectura
8.13.1 Vectura Comapny Information
8.13.2 Vectura Business Overview
8.13.3 Vectura Dry Powder Inhaler Device Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 Vectura Dry Powder Inhaler Device Product Portfolio
8.13.5 Vectura Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Dry Powder Inhaler Device Value Chain Analysis
9.1.1 Dry Powder Inhaler Device Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Dry Powder Inhaler Device Production Mode & Process
9.2 Dry Powder Inhaler Device Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Dry Powder Inhaler Device Distributors
9.2.3 Dry Powder Inhaler Device Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
LIST OF TABLES
Table 1. Dry Powder Inhaler Device Industry Trends
Table 2. Dry Powder Inhaler Device Industry Drivers
Table 3. Dry Powder Inhaler Device Industry Opportunities and Challenges
Table 4. Dry Powder Inhaler Device Industry Restraints
Table 5. Global Dry Powder Inhaler Device Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Dry Powder Inhaler Device Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Dry Powder Inhaler Device Sales by Manufacturers (K Units) & (2019-2024)
Table 8. Global Dry Powder Inhaler Device Sales Market Share by Manufacturers
Table 9. Global Dry Powder Inhaler Device Average Sales Price (USD/Unit) of Manufacturers (2019-2024)
Table 10. Global Dry Powder Inhaler Device Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Dry Powder Inhaler Device Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Dry Powder Inhaler Device Manufacturers, Product Type & Application
Table 13. Global Dry Powder Inhaler Device Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Dry Powder Inhaler Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Single Dose
Table 17. Major Manufacturers of Multi Dose
Table 18. Global Dry Powder Inhaler Device Sales by Type 2019 VS 2023 VS 2030 (K Units)
Table 19. Global Dry Powder Inhaler Device Sales by Type (2019-2024) & (K Units)
Table 20. Global Dry Powder Inhaler Device Sales by Type (2025-2030) & (K Units)
Table 21. Global Dry Powder Inhaler Device Sales Market Share by Type (2019-2024)
Table 22. Global Dry Powder Inhaler Device Sales Market Share by Type (2025-2030)
Table 23. Global Dry Powder Inhaler Device Revenue by Type 2019 VS 2023 VS 2030 (K Units)
Table 24. Global Dry Powder Inhaler Device Revenue by Type (2019-2024) & (K Units)
Table 25. Global Dry Powder Inhaler Device Revenue by Type (2025-2030) & (K Units)
Table 26. Global Dry Powder Inhaler Device Revenue Market Share by Type (2019-2024)
Table 27. Global Dry Powder Inhaler Device Revenue Market Share by Type (2025-2030)
Table 28. Major Manufacturers of Asthma
Table 29. Major Manufacturers of COPD
Table 30. Major Manufacturers of Others
Table 31. Global Dry Powder Inhaler Device Sales by Application 2019 VS 2023 VS 2030 (K Units)
Table 32. Global Dry Powder Inhaler Device Sales by Application (2019-2024) & (K Units)
Table 33. Global Dry Powder Inhaler Device Sales by Application (2025-2030) & (K Units)
Table 34. Global Dry Powder Inhaler Device Sales Market Share by Application (2019-2024)
Table 35. Global Dry Powder Inhaler Device Sales Market Share by Application (2025-2030)
Table 36. Global Dry Powder Inhaler Device Revenue by Application 2019 VS 2023 VS 2030 (K Units)
Table 37. Global Dry Powder Inhaler Device Revenue by Application (2019-2024) & (K Units)
Table 38. Global Dry Powder Inhaler Device Revenue by Application (2025-2030) & (K Units)
Table 39. Global Dry Powder Inhaler Device Revenue Market Share by Application (2019-2024)
Table 40. Global Dry Powder Inhaler Device Revenue Market Share by Application (2025-2030)
Table 41. Global Dry Powder Inhaler Device Sales by Region: 2019 VS 2023 VS 2030 (K Units)
Table 42. Global Dry Powder Inhaler Device Sales by Region (2019-2024) & (K Units)
Table 43. Global Dry Powder Inhaler Device Sales Market Share by Region (2019-2024)
Table 44. Global Dry Powder Inhaler Device Sales Forecasted by Region (2025-2030) & (K Units)
Table 45. Global Dry Powder Inhaler Device Sales Forecasted Market Share by Region (2025-2030)
Table 46. North America Dry Powder Inhaler Device Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
Table 47. North America Dry Powder Inhaler Device Sales by Country (2019-2024) & (K Units)
Table 48. North America Dry Powder Inhaler Device Sales by Country (2025-2030) & (K Units)
Table 49. Europe Dry Powder Inhaler Device Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
Table 50. Europe Dry Powder Inhaler Device Sales by Country (2019-2024) & (K Units)
Table 51. Europe Dry Powder Inhaler Device Sales by Country (2025-2030) & (K Units)
Table 52. Asia Pacific Dry Powder Inhaler Device Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
Table 53. Asia Pacific Dry Powder Inhaler Device Sales by Country (2019-2024) & (K Units)
Table 54. Asia Pacific Dry Powder Inhaler Device Sales by Country (2025-2030) & (K Units)
Table 55. LAMEA Dry Powder Inhaler Device Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
Table 56. LAMEA Dry Powder Inhaler Device Sales by Country (2019-2024) & (K Units)
Table 57. LAMEA Dry Powder Inhaler Device Sales by Country (2025-2030) & (K Units)
Table 58. Global Dry Powder Inhaler Device Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. Global Dry Powder Inhaler Device Revenue by Region (2019-2024) & (US$ Million)
Table 60. Global Dry Powder Inhaler Device Revenue by Region (2025-2030) & (US$ Million)
Table 61. Global Dry Powder Inhaler Device Revenue Market Share by Region (2019-2024)
Table 62. Global Dry Powder Inhaler Device Revenue Market Share by Region (2025-2030)
Table 63. GlaxoSmithKline Company Information
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 66. GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio
Table 67. GlaxoSmithKline Recent Development
Table 68. AstraZeneca Company Information
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 71. AstraZeneca Dry Powder Inhaler Device Product Portfolio
Table 72. AstraZeneca Recent Development
Table 73. Boehringer Ingelheim Company Information
Table 74. Boehringer Ingelheim Business Overview
Table 75. Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 76. Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio
Table 77. Boehringer Ingelheim Recent Development
Table 78. Chiesi Company Information
Table 79. Chiesi Business Overview
Table 80. Chiesi Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 81. Chiesi Dry Powder Inhaler Device Product Portfolio
Table 82. Chiesi Recent Development
Table 83. Cipla Company Information
Table 84. Cipla Business Overview
Table 85. Cipla Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 86. Cipla Dry Powder Inhaler Device Product Portfolio
Table 87. Cipla Recent Development
Table 88. 3M Company Information
Table 89. 3M Business Overview
Table 90. 3M Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 91. 3M Dry Powder Inhaler Device Product Portfolio
Table 92. 3M Recent Development
Table 93. Hovione Company Information
Table 94. Hovione Business Overview
Table 95. Hovione Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 96. Hovione Dry Powder Inhaler Device Product Portfolio
Table 97. Hovione Recent Development
Table 98. Mannkind Company Information
Table 99. Mannkind Business Overview
Table 100. Mannkind Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 101. Mannkind Dry Powder Inhaler Device Product Portfolio
Table 102. Mannkind Recent Development
Table 103. Mylan Company Information
Table 104. Mylan Business Overview
Table 105. Mylan Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 106. Mylan Dry Powder Inhaler Device Product Portfolio
Table 107. Mylan Recent Development
Table 108. Novartis Company Information
Table 109. Novartis Business Overview
Table 110. Novartis Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 111. Novartis Dry Powder Inhaler Device Product Portfolio
Table 112. Novartis Recent Development
Table 113. Schering/Merck Company Information
Table 114. Schering/Merck Business Overview
Table 115. Schering/Merck Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 116. Schering/Merck Dry Powder Inhaler Device Product Portfolio
Table 117. Schering/Merck Recent Development
Table 118. Teva Company Information
Table 119. Teva Business Overview
Table 120. Teva Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 121. Teva Dry Powder Inhaler Device Product Portfolio
Table 122. Teva Recent Development
Table 123. Vectura Company Information
Table 124. Vectura Business Overview
Table 125. Vectura Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 126. Vectura Dry Powder Inhaler Device Product Portfolio
Table 127. Vectura Recent Development
Table 128. Key Raw Materials
Table 129. Raw Materials Key Suppliers
Table 130. Dry Powder Inhaler Device Distributors List
Table 131. Dry Powder Inhaler Device Customers List
Table 132. Research Programs/Design for This Report
Table 133. Authors List of This Report
Table 134. Secondary Sources
Table 135. Primary Sources
Table 1. Dry Powder Inhaler Device Industry Trends
Table 2. Dry Powder Inhaler Device Industry Drivers
Table 3. Dry Powder Inhaler Device Industry Opportunities and Challenges
Table 4. Dry Powder Inhaler Device Industry Restraints
Table 5. Global Dry Powder Inhaler Device Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Dry Powder Inhaler Device Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Dry Powder Inhaler Device Sales by Manufacturers (K Units) & (2019-2024)
Table 8. Global Dry Powder Inhaler Device Sales Market Share by Manufacturers
Table 9. Global Dry Powder Inhaler Device Average Sales Price (USD/Unit) of Manufacturers (2019-2024)
Table 10. Global Dry Powder Inhaler Device Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Dry Powder Inhaler Device Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Dry Powder Inhaler Device Manufacturers, Product Type & Application
Table 13. Global Dry Powder Inhaler Device Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Dry Powder Inhaler Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of Single Dose
Table 17. Major Manufacturers of Multi Dose
Table 18. Global Dry Powder Inhaler Device Sales by Type 2019 VS 2023 VS 2030 (K Units)
Table 19. Global Dry Powder Inhaler Device Sales by Type (2019-2024) & (K Units)
Table 20. Global Dry Powder Inhaler Device Sales by Type (2025-2030) & (K Units)
Table 21. Global Dry Powder Inhaler Device Sales Market Share by Type (2019-2024)
Table 22. Global Dry Powder Inhaler Device Sales Market Share by Type (2025-2030)
Table 23. Global Dry Powder Inhaler Device Revenue by Type 2019 VS 2023 VS 2030 (K Units)
Table 24. Global Dry Powder Inhaler Device Revenue by Type (2019-2024) & (K Units)
Table 25. Global Dry Powder Inhaler Device Revenue by Type (2025-2030) & (K Units)
Table 26. Global Dry Powder Inhaler Device Revenue Market Share by Type (2019-2024)
Table 27. Global Dry Powder Inhaler Device Revenue Market Share by Type (2025-2030)
Table 28. Major Manufacturers of Asthma
Table 29. Major Manufacturers of COPD
Table 30. Major Manufacturers of Others
Table 31. Global Dry Powder Inhaler Device Sales by Application 2019 VS 2023 VS 2030 (K Units)
Table 32. Global Dry Powder Inhaler Device Sales by Application (2019-2024) & (K Units)
Table 33. Global Dry Powder Inhaler Device Sales by Application (2025-2030) & (K Units)
Table 34. Global Dry Powder Inhaler Device Sales Market Share by Application (2019-2024)
Table 35. Global Dry Powder Inhaler Device Sales Market Share by Application (2025-2030)
Table 36. Global Dry Powder Inhaler Device Revenue by Application 2019 VS 2023 VS 2030 (K Units)
Table 37. Global Dry Powder Inhaler Device Revenue by Application (2019-2024) & (K Units)
Table 38. Global Dry Powder Inhaler Device Revenue by Application (2025-2030) & (K Units)
Table 39. Global Dry Powder Inhaler Device Revenue Market Share by Application (2019-2024)
Table 40. Global Dry Powder Inhaler Device Revenue Market Share by Application (2025-2030)
Table 41. Global Dry Powder Inhaler Device Sales by Region: 2019 VS 2023 VS 2030 (K Units)
Table 42. Global Dry Powder Inhaler Device Sales by Region (2019-2024) & (K Units)
Table 43. Global Dry Powder Inhaler Device Sales Market Share by Region (2019-2024)
Table 44. Global Dry Powder Inhaler Device Sales Forecasted by Region (2025-2030) & (K Units)
Table 45. Global Dry Powder Inhaler Device Sales Forecasted Market Share by Region (2025-2030)
Table 46. North America Dry Powder Inhaler Device Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
Table 47. North America Dry Powder Inhaler Device Sales by Country (2019-2024) & (K Units)
Table 48. North America Dry Powder Inhaler Device Sales by Country (2025-2030) & (K Units)
Table 49. Europe Dry Powder Inhaler Device Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
Table 50. Europe Dry Powder Inhaler Device Sales by Country (2019-2024) & (K Units)
Table 51. Europe Dry Powder Inhaler Device Sales by Country (2025-2030) & (K Units)
Table 52. Asia Pacific Dry Powder Inhaler Device Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
Table 53. Asia Pacific Dry Powder Inhaler Device Sales by Country (2019-2024) & (K Units)
Table 54. Asia Pacific Dry Powder Inhaler Device Sales by Country (2025-2030) & (K Units)
Table 55. LAMEA Dry Powder Inhaler Device Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Units)
Table 56. LAMEA Dry Powder Inhaler Device Sales by Country (2019-2024) & (K Units)
Table 57. LAMEA Dry Powder Inhaler Device Sales by Country (2025-2030) & (K Units)
Table 58. Global Dry Powder Inhaler Device Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. Global Dry Powder Inhaler Device Revenue by Region (2019-2024) & (US$ Million)
Table 60. Global Dry Powder Inhaler Device Revenue by Region (2025-2030) & (US$ Million)
Table 61. Global Dry Powder Inhaler Device Revenue Market Share by Region (2019-2024)
Table 62. Global Dry Powder Inhaler Device Revenue Market Share by Region (2025-2030)
Table 63. GlaxoSmithKline Company Information
Table 64. GlaxoSmithKline Business Overview
Table 65. GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 66. GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio
Table 67. GlaxoSmithKline Recent Development
Table 68. AstraZeneca Company Information
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 71. AstraZeneca Dry Powder Inhaler Device Product Portfolio
Table 72. AstraZeneca Recent Development
Table 73. Boehringer Ingelheim Company Information
Table 74. Boehringer Ingelheim Business Overview
Table 75. Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 76. Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio
Table 77. Boehringer Ingelheim Recent Development
Table 78. Chiesi Company Information
Table 79. Chiesi Business Overview
Table 80. Chiesi Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 81. Chiesi Dry Powder Inhaler Device Product Portfolio
Table 82. Chiesi Recent Development
Table 83. Cipla Company Information
Table 84. Cipla Business Overview
Table 85. Cipla Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 86. Cipla Dry Powder Inhaler Device Product Portfolio
Table 87. Cipla Recent Development
Table 88. 3M Company Information
Table 89. 3M Business Overview
Table 90. 3M Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 91. 3M Dry Powder Inhaler Device Product Portfolio
Table 92. 3M Recent Development
Table 93. Hovione Company Information
Table 94. Hovione Business Overview
Table 95. Hovione Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 96. Hovione Dry Powder Inhaler Device Product Portfolio
Table 97. Hovione Recent Development
Table 98. Mannkind Company Information
Table 99. Mannkind Business Overview
Table 100. Mannkind Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 101. Mannkind Dry Powder Inhaler Device Product Portfolio
Table 102. Mannkind Recent Development
Table 103. Mylan Company Information
Table 104. Mylan Business Overview
Table 105. Mylan Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 106. Mylan Dry Powder Inhaler Device Product Portfolio
Table 107. Mylan Recent Development
Table 108. Novartis Company Information
Table 109. Novartis Business Overview
Table 110. Novartis Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 111. Novartis Dry Powder Inhaler Device Product Portfolio
Table 112. Novartis Recent Development
Table 113. Schering/Merck Company Information
Table 114. Schering/Merck Business Overview
Table 115. Schering/Merck Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 116. Schering/Merck Dry Powder Inhaler Device Product Portfolio
Table 117. Schering/Merck Recent Development
Table 118. Teva Company Information
Table 119. Teva Business Overview
Table 120. Teva Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 121. Teva Dry Powder Inhaler Device Product Portfolio
Table 122. Teva Recent Development
Table 123. Vectura Company Information
Table 124. Vectura Business Overview
Table 125. Vectura Dry Powder Inhaler Device Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 126. Vectura Dry Powder Inhaler Device Product Portfolio
Table 127. Vectura Recent Development
Table 128. Key Raw Materials
Table 129. Raw Materials Key Suppliers
Table 130. Dry Powder Inhaler Device Distributors List
Table 131. Dry Powder Inhaler Device Customers List
Table 132. Research Programs/Design for This Report
Table 133. Authors List of This Report
Table 134. Secondary Sources
Table 135. Primary Sources
LIST OF FIGURES
Figure 1. Dry Powder Inhaler Device Product Picture
Figure 2. Global Dry Powder Inhaler Device Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Dry Powder Inhaler Device Market Size (2019-2030) & (US$ Million)
Figure 4. Global Dry Powder Inhaler Device Sales (2019-2030) & (K Units)
Figure 5. Global Dry Powder Inhaler Device Average Price (USD/Unit) & (2019-2030)
Figure 6. Global Top 5 and 10 Dry Powder Inhaler Device Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Single Dose Picture
Figure 9. Multi Dose Picture
Figure 10. Global Dry Powder Inhaler Device Sales by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 11. Global Dry Powder Inhaler Device Sales Market Share 2019 VS 2023 VS 2030
Figure 12. Global Dry Powder Inhaler Device Sales Market Share by Type (2019-2030)
Figure 13. Global Dry Powder Inhaler Device Revenue by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 14. Global Dry Powder Inhaler Device Revenue Market Share 2019 VS 2023 VS 2030
Figure 15. Global Dry Powder Inhaler Device Revenue Market Share by Type (2019-2030)
Figure 16. Asthma Picture
Figure 17. COPD Picture
Figure 18. Others Picture
Figure 19. Global Dry Powder Inhaler Device Sales by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 20. Global Dry Powder Inhaler Device Sales Market Share 2019 VS 2023 VS 2030
Figure 21. Global Dry Powder Inhaler Device Sales Market Share by Application (2019-2030)
Figure 22. Global Dry Powder Inhaler Device Revenue by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 23. Global Dry Powder Inhaler Device Revenue Market Share 2019 VS 2023 VS 2030
Figure 24. Global Dry Powder Inhaler Device Revenue Market Share by Application (2019-2030)
Figure 25. North America Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 26. North America Dry Powder Inhaler Device Sales Market Share by Country (2019-2030)
Figure 27. U.S. Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 28. Canada Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 29. Europe Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 30. Europe Dry Powder Inhaler Device Sales Market Share by Country (2019-2030)
Figure 31. Germany Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 32. France Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 33. U.K. Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 34. Italy Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 35. Netherlands Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 36. Asia Pacific Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 37. Asia Pacific Dry Powder Inhaler Device Sales Market Share by Country (2019-2030)
Figure 38. China Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 39. Japan Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 40. South Korea Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 41. Southeast Asia Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 42. India Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 43. Australia Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 44. LAMEA Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 45. LAMEA Dry Powder Inhaler Device Sales Market Share by Country (2019-2030)
Figure 46. Mexico Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 47. Brazil Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 48. Turkey Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 49. GCC Countries Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 50. Global Dry Powder Inhaler Device Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Global Dry Powder Inhaler Device Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 52. North America Dry Powder Inhaler Device Revenue (2019-2030) & (US$ Million)
Figure 53. North America Dry Powder Inhaler Device Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 54. Europe Dry Powder Inhaler Device Revenue (2019-2030) & (US$ Million)
Figure 55. Europe Dry Powder Inhaler Device Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 56. Asia-Pacific Dry Powder Inhaler Device Revenue (2019-2030) & (US$ Million)
Figure 57. Asia-Pacific Dry Powder Inhaler Device Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 58. LAMEA Dry Powder Inhaler Device Revenue (2019-2030) & (US$ Million)
Figure 59. LAMEA Dry Powder Inhaler Device Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 60. Dry Powder Inhaler Device Value Chain
Figure 61. Manufacturing Cost Structure
Figure 62. Dry Powder Inhaler Device Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Years Considered
Figure 66. Research Process
Figure 67. Key Executives Interviewed
Figure 1. Dry Powder Inhaler Device Product Picture
Figure 2. Global Dry Powder Inhaler Device Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Dry Powder Inhaler Device Market Size (2019-2030) & (US$ Million)
Figure 4. Global Dry Powder Inhaler Device Sales (2019-2030) & (K Units)
Figure 5. Global Dry Powder Inhaler Device Average Price (USD/Unit) & (2019-2030)
Figure 6. Global Top 5 and 10 Dry Powder Inhaler Device Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Single Dose Picture
Figure 9. Multi Dose Picture
Figure 10. Global Dry Powder Inhaler Device Sales by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 11. Global Dry Powder Inhaler Device Sales Market Share 2019 VS 2023 VS 2030
Figure 12. Global Dry Powder Inhaler Device Sales Market Share by Type (2019-2030)
Figure 13. Global Dry Powder Inhaler Device Revenue by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 14. Global Dry Powder Inhaler Device Revenue Market Share 2019 VS 2023 VS 2030
Figure 15. Global Dry Powder Inhaler Device Revenue Market Share by Type (2019-2030)
Figure 16. Asthma Picture
Figure 17. COPD Picture
Figure 18. Others Picture
Figure 19. Global Dry Powder Inhaler Device Sales by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 20. Global Dry Powder Inhaler Device Sales Market Share 2019 VS 2023 VS 2030
Figure 21. Global Dry Powder Inhaler Device Sales Market Share by Application (2019-2030)
Figure 22. Global Dry Powder Inhaler Device Revenue by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 23. Global Dry Powder Inhaler Device Revenue Market Share 2019 VS 2023 VS 2030
Figure 24. Global Dry Powder Inhaler Device Revenue Market Share by Application (2019-2030)
Figure 25. North America Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 26. North America Dry Powder Inhaler Device Sales Market Share by Country (2019-2030)
Figure 27. U.S. Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 28. Canada Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 29. Europe Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 30. Europe Dry Powder Inhaler Device Sales Market Share by Country (2019-2030)
Figure 31. Germany Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 32. France Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 33. U.K. Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 34. Italy Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 35. Netherlands Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 36. Asia Pacific Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 37. Asia Pacific Dry Powder Inhaler Device Sales Market Share by Country (2019-2030)
Figure 38. China Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 39. Japan Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 40. South Korea Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 41. Southeast Asia Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 42. India Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 43. Australia Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 44. LAMEA Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 45. LAMEA Dry Powder Inhaler Device Sales Market Share by Country (2019-2030)
Figure 46. Mexico Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 47. Brazil Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 48. Turkey Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 49. GCC Countries Dry Powder Inhaler Device Sales and Growth Rate (2019-2030) & (K Units)
Figure 50. Global Dry Powder Inhaler Device Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Global Dry Powder Inhaler Device Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 52. North America Dry Powder Inhaler Device Revenue (2019-2030) & (US$ Million)
Figure 53. North America Dry Powder Inhaler Device Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 54. Europe Dry Powder Inhaler Device Revenue (2019-2030) & (US$ Million)
Figure 55. Europe Dry Powder Inhaler Device Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 56. Asia-Pacific Dry Powder Inhaler Device Revenue (2019-2030) & (US$ Million)
Figure 57. Asia-Pacific Dry Powder Inhaler Device Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 58. LAMEA Dry Powder Inhaler Device Revenue (2019-2030) & (US$ Million)
Figure 59. LAMEA Dry Powder Inhaler Device Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 60. Dry Powder Inhaler Device Value Chain
Figure 61. Manufacturing Cost Structure
Figure 62. Dry Powder Inhaler Device Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Years Considered
Figure 66. Research Process
Figure 67. Key Executives Interviewed
